NCT07086924View on ClinicalTrials.gov

Genetic Variation in TRAF3IP2 (rs13190932)

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

June 10, 2026

Conditions
PsoriasisPsoriatic Arthritis
Interventions
DRUG

Methotrexate

Assessing the response of psoriasis and psoriatic arthritis to Methotrexate. and also Assessing the pharmacogenetic association between TRAF3IP2 ( rs13190932 ) gene Polymorphism in psoriatic and psoriatic arthritis patients taking Methotrexate.

Trial Locations (1)

Unknown

RECRUITING

Qena Hospital, Qina

All Listed Sponsors
lead

South Valley University

OTHER